Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]-Fludarabine PET/MR in CNS Lymphoma
NCT05390814Phase 1Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Measurements of [18F]-Fludarabine uptake in tumoral lesions and normal tissue using SUV, tumor/normal tissues ratios at 15 days. Started Dec 2023; status: completed.
Beyond the preview
Go deeper on NCT05390814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05390814.